There has been an increase in the prevalence of otomycosis in recent years. This has been linked to the extensive use of antibiotic eardrops. Treatment of otomycosis is challenging, and requires a close follow-up. We present a review of the literature on otomycosis, the topical antifungals most commonly used, and discuss their ototoxic potential. Candida albicans and Aspergillus are the most commonly identified organisms. Antifungals from the Azole class seem to be the most effective, followed by Nystatin and Tolnaftate.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijporl.2007.12.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinicopathological study of otomycosis in a tertiary hospital in South-west Nigeria.
Afr Health Sci
March 2024
Department of Medical Microbiology and Parasitology, Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria.
Background: Otomycosis is common in environments with hot, humid weather, and it may be challenging to manage.
Objectives: To profile common clinical presentations, the pathogenic fungi, the treatment modalities with responses, and explore clinical factors associated with having positive fungal culture in Otomycosis.
Methods: Retrospective review of patients with Otomycosis.
Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.
Curr Med Mycol
June 2020
Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background And Purpose: Otomycosis is a secondary ear fungal infection among predisposed individuals in humid conditions. species are the most common etiologic agents of this infection. Several ototopical antifungals are currently used for the treatment of this disease; however, recurrence and treatment failure are usually observed in some cases.
View Article and Find Full Text PDFFirst reported case of multidrug-resistant in Canada.
Can Commun Dis Rep
July 2017
Section of Infectious Diseases, Departments of Internal Medicine and Medical Microbiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB.
is a fungal pathogen that has recently emerged as a global threat to public health. It was first described in Japan in 2009 and has since been reported in 17 countries on five continents. This case report describes the first reported case of multidrug-resistant in Canada.
View Article and Find Full Text PDFThe Effect of Nystatin Solution on Otoacoustic Emissions in Rats.
J Int Adv Otol
April 2017
Department of Otorhinolaryngology, Erciyes University School of Medicine, Kayseri, Turkey.
Objective: In patients with a perforated tympanic membrane, topically administered medication reaches the middle ear and thus creates a risk of ototoxicity. The aim of the present study was to evaluate the possible ototoxic effect of the antifungal medication nystatin when administered to the rat middle ear cavity.
Materials And Methods: Three groups (negative control, positive control, and study groups), each containing eight rats, were formed.
Otomycosis in Shanghai: aetiology, clinical features and therapy.
Mycoses
September 2012
Medicine Doctor, Department of Otolaryngology, Eye Ear Nose & Throat Hospital, Fudan University, Shanghai, China.
Otomycosis is frequently seen in Shanghai and is a challenging problem due to recurrence and resistance to therapy. The aims of this study were to determine the pattern of fungal agents, sex distribution, clinical presentation, predisposing factors, complications and treatment outcomes of otomycosis. Retrospective review of 108 patients with a clinical diagnosis of otomycosis treated from September 2009 to September 2010 in otolaryngology outpatient department.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!